Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mycobacteriology and Aerobic Actinomycetes

Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques

Marjorie L. Beggs, Rossina Stevanova, Kathleen D. Eisenach
Marjorie L. Beggs
Departments of Pathology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rossina Stevanova
Anatomy, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen D. Eisenach
Departments of Pathology,
Microbiology and Immunology, University of Arkansas for Medical Sciences, and J. L. McClellan Memorial Veterans Hospital, Little Rock, Arkansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.38.2.508-512.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Organisms in the Mycobacterium avium complex (MAC;M. avium, M. intracellulare, and “nonspecific or X” MAC) are emerging pathogens among individual organisms of which significant genetic variability is displayed. The objective of the present study was to evaluate various molecular methods for the rapid and definitive identification of MAC species. Isolates were obtained from both human immunodeficiency virus (HIV)-positive patients and HIV-negative patients with and without known predisposing conditions. The isolates were initially hybridized with nucleic acid probes complementary to the rRNA of the respective mycobacterial species (AccuProbe Culture Confirmation kits for M. avium, M. intracellulare, and MAC species; Gen-Probe). Isolates were also examined by PCR and in some cases by Southern blot hybridization for the insertion element IS1245. Two other techniques included a PCR assay that amplifies the mig gene, a putative virulence factor for MAC, and hsp65 gene amplification and sequencing. This study led to the following observations. Eighty-five percent of the isolates from HIV-positive patients were M. avium and 86% of the isolates from HIV-negative patients wereM. intracellulare. Fifteen of the M. aviumisolates did not contain IS1245 and 7% of the M. intracellulare isolates were found to carry IS1245. All of the M. avium strains were mig positive, and all of the M. intracellulare strains weremig negative.

Organisms in the Mycobacterium avium complex (MAC) are opportunistic pathogens that can be isolated from soil and water and cause infection and clinical disease in a wide variety of animals and humans (9). Many M. avium infections are seen in patients who are immunocompromised, such as those with AIDS (5). These infections are usually disseminated and have been shown to contribute significantly to the morbidity of AIDS patients (7). Prior to the advent of AIDS, most patients in the United States with MAC pulmonary disease were elderly males who had underlying lung diseases, such as bronchitis, emphysema, prior tuberculosis, and other fibrotic disorders. More recently, MAC pulmonary disease has been diagnosed in an increasing number of women who have no history of underlying lung disorders and who appear to be immunocompetent (10, 17, 18, 24, 25).

The objective of this study was to evaluate various molecular methods for the rapid and definitive identification of MAC species (M. avium, M. intracellulare, and “nonspecific or X” MAC). MAC isolates from the three human populations described above were included in the study. The isolates were initially hybridized with nucleic acid probes complementary to the rRNA of the respective mycobacterial species (AccuProbe Culture Confirmation kits for M. avium, M. intracellulare, and MAC species; Gen-Probe Inc., San Diego, Calif.). These kits are routinely used in clinical mycobacteriology laboratories for the rapid identification of mycobacterial species. Isolates were also examined by PCR and in some cases by Southern blot hybridization for the insertion element IS1245 because it has been suggested to be specific forM. avium (6). Two other techniques included a PCR assay that amplifies the mig gene, a putative virulence factor for MAC, and hsp65 gene amplification and sequencing (16, 23). The combination of these techniques has yielded new information concerning clinical MAC isolates.

MATERIALS AND METHODS

MAC isolates.A patient profile sheet was obtained for each human isolate. The strains used in this study were obtained from the following sources: Walter Pace, University of Arkansas for Medical Sciences clinical laboratory and the John L. McClellan Memorial Veteran's Hospital clinical laboratory; Richard Wallace and Barbara Brown, Department of Microbiology, University of Texas Health Center at Tyler; Leonid Heifets and Gwen Huitt, National Jewish Center for Immunology and Respiratory Medicine; Richard J. Blinkhorn, MetroHealth Medical Center Clinical Laboratory, Cleveland, Ohio; Hiroe Shiratsuchi, Case Western Reserve University, Cleveland, Ohio; and William Stead, Arkansas State Health Laboratory. The isolates from the United Kingdom were received from Jack Crawford, Centers for Disease Control and Prevention, Atlanta, Ga., and were isolated by Tobin Hellyer, Becton-Dickinson Corp., Baltimore, Md.

In some cases the isolates had been streaked for isolation and single colonies had been selected before being sent to us. All other isolates, upon receipt, were streaked onto 7H11 plates and were examined for colonial morphology in our laboratory. Single colonies were selected and cultivated in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI), two aliquots were frozen, and the remainder of the culture was used for DNA isolation and pulsed-field gel electrophoresis (PFGE).

Testing with Gen-Probe kits.Culture confirmation kits (AccuProbe; Gen-Probe) were used to determine the species of each isolate. The M. avium probe kit detects M. aviumisolates, the M. intracellulare probe kit detects M. intracellulare isolates, and the MAC probe kit detects M. avium, M. intracellulare, and MAC isolates which are designated X or nonspecific MAC and which are not detected by either species-specific probe (3). Each test was performed by following the manufacturer's instructions and with the inclusion of controls.

Each isolate was tested with the MAC AccuProbe kit to confirm that the isolates belonged to MAC. Isolates were then tested with the M. avium-specific AccuProbe, and all positive isolates were given a number preceded by an “A” to identify them as M. aviumisolates. Isolates that were positive with the MAC-specific AccuProbe but negative with the M. avium-specific probe were tested with the M. intracellulare-specific AccuProbe. Isolates that were positive with this probe were given a number preceded by “I” to identify them as M. intracellulare isolates. Isolates that were positive with the MAC-specific probe but that were negative with the M. avium-specific or the M. intracellulare-specific probe were given a number preceded by “X” to identify them as nonspecific MAC isolates.

Preparation of genomic DNAs from mycobacteria.The following large-scale DNA preparation method was developed in our laboratory. For DNA preparation, mycobacterial cells (10 to 100 ml) were incubated to a Klett reading of 100 to 150, which represents logarithmic-phase growth, and were treated with d-cycloserine (1 mg/ml) for 24 h. After sedimentation in the centrifuge, the cell pellets were heat killed, resuspended in 1 ml of lysing buffer (4 mM Tris HCl [pH 8.0], 4% sodium dodecyl sulfate, 10 mM NaCl, 0.001 mM EDTA, 0.1 mg of proteinase K per ml), and incubated at 37°C overnight or at 68°C for 2 h. The lysate was cooled to room temperature, and the debris was pelleted by centrifugation. The supernatant was extracted two times with phenol-chloroform in phase-lock gel tubes (Five Prime to Three Prime Inc., Boulder, Colo.). After a final extraction in chloroform the aqueous phase was precipitated with 0.3 M sodium acetate (pH 5.5) and 2 volumes of ethanol for 15 min at −70°C. Preparations were centrifuged for 20 min at 4°C, washed one time with 70% ethanol, dried, and reconstituted in TE (Tris-EDTA) buffer. Yields were approximately 200 to 1,000 ng/μl.

PCR assays.DNA amplification was performed on a GeneAmp PCR system 9600 (Perkin-Elmer, Norwalk, Conn.) in a 50-μl reaction mixture containing 10 pmol of each primer, 1 ng of genomic DNA, 200 μM deoxyribonucleoside triphosphates, 1× PCR buffer (1.5 mM MgCl2 [pH 8.3]; Perkin-Elmer), and 1 U of TaqDNA polymerase (Perkin-Elmer). Occasionally, the organisms were tested directly in the PCR without prior DNA extraction. In this case, a sterile toothpick was used to obtain cells from a colony, and the cells were added directly to 49 μl of the complete PCR mixture. Primers and conditions for IS1245 PCR were as reported and amplify IS1245 and the closely related element IS1311(6, 20). The primers specific for the mig gene were designed to amplify a 737-bp fragment within the coding region of the gene (16). The mig-specific primer sequences were as follows: mig upper, 5′-CCC GTT CAA CGT CAA CTT CC-3′; mig lower, 5′-GGG CTC GCC GGT CAT CAG GT-3′. The cycling conditions were as follows: initial denaturation at 95°C for 5 min and 30 cycles of 30 s of denaturation at 95°C and 2.0 min of annealing and extension at 68°C, followed by a single 5-min extension at 72°C. The PCR products were electrophoresed on a 2% agarose gel, with a 1-kb DNA ladder used for size determination (Gibco Life Technologies, Grand Island, N.Y.), stained with ethidium bromide, and photographed by using the Eagle Eye II gel documentation system (Stratagene, La Jolla, Calif.).

Fingerprinting with IS1245.For fingerprinting with IS1245 (6), isolated genomic DNA (500 ng) was digested with the restriction enzyme PvuII, electrophoresed on a 0.7% gel, alkaline transferred to Hybond (Amersham Pharmacia Biotech, Piscataway, N.J.), probed with a 427-bp fragment of IS1245 produced by PCR, and labeled with [32P]dCTP with the Random Primed DNA Labeling Kit (Boehringer Mannheim, Mannheim, Germany). The gel images were saved in tif format and were analyzed by using the PFGE program described below.

PFGE and analysis.Whole cellular DNA for the experiments was prepared essentially as described by Zhang et al. (26). Bacterial DNA slices were restricted with the low-frequency-cleavage restriction endonuclease XbaI and in some cases withSpeI (New England Biolabs, Beverly, Mass.). In order to detect large plasmids, whole cellular DNA was electrophoresed without prior digestion with a restriction endonuclease. PFGE of the digested or undigested DNA samples was performed in a contour-clamped homogeneous electric field on the CHEF-DR II system (Bio-Rad Laboratories, Richmond, Calif.) in 0.8% low-endosmosis agarose gels (Pulsed Field Certified Agarose; Bio-Rad Laboratories) at a ramped pulse time from 5 to 30 s for 24 h. DNA size standards consisting of concatemers of bacteriophage lambda DNA (Bio-Rad Laboratories) were included in each gel.

After electrophoresis, the gels were stained with ethidium bromide, destained in distilled water, and visualized on a UV transilluminator (Stratagene), and a tif image of each gel was stored on a diskette. The profiles were scanned and analyzed with the Molecular Analyst Fingerprinting software (Bio-Rad Laboratories). This package enables conversion of the gel image, normalization to a universal standard, analysis of the macrorestriction patterns, and cluster analysis of the PFGE or IS1245 patterns. By using the hierarchic unweighted pair group average method as a clustering algorithm and the Jaccard coefficient of similarity, dendrograms for the isolates from each subtype were created.

hsp65 sequencing.The hsp65 gene encodes a 65-kDa heat shock protein and has been used to identify species in the MAC complex (11, 21-23). Amplification and sequencing of the 441-bp segment of the hsp65 gene were performed for selected strains, as described elsewhere (23).

RESULTS

Strain identification with Gen-Probe kits.An integral aspect of this study was identification of MAC isolates from human immunodeficiency virus (HIV)-positive and HIV-negative patients to the species level. The most common method of species identification of MAC organisms is by use of the 16S ribosomal gene sequence, which is the basis of the Gen-Probe assay. We identified 92 M. aviumisolates 75 of which were from HIV-positive patients and 17 of which were from HIV-negative patients; 57 M. intracellulareisolates, 7 of which were from HIV-positive individuals and 50 of which were from HIV-negative patients; and 12 nonspecific or X isolates, 5 of which were from HIV-positive patients and 7 of which were from HIV-negative patients.

IS1245 fingerprinting.During this study all isolates were checked for the presence of the insertion element IS1245 by PCR (6) (Table1). Fourteen M. avium isolates (15%) did not contain IS1245 by PCR. These isolates were checked for the presence of IS1245 by Southern blot hybridization, with the same negative results (data not shown).

View this table:
  • View inline
  • View popup
Table 1.

Summary of IS1245 and mig gene data for all isolates

Three of the IS1245-negative M. avium isolates were from HIV-positive patients in the United Kingdom. The remaining 11 isolates were from Cleveland, and all but 1 of these isolates were from HIV-positive patients. To verify that the Cleveland isolates were not identical, they were digested with XbaI, electrophoresed on a single pulsed-field gel, and analyzed (Fig.1). The results showed that two of the isolates (isolates A67 and A73) shared identical patterns, while the remainder of the isolates had unique patterns. When A67 and A73 were run after SpeI digestion, there was a single band difference which has been determined to be a large plasmid in A73 (data not shown). Therefore, these isolates would be considered identical or essentially the same.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

PFGE patterns of IS1245-negative M. avium isolates from Cleveland. Lane L, 48.5-kbp bacteriophage lambda concameter ladder (numbers on the right are in kilobase pairs); lane 1, A54; lane 2, A67; lane 3, A71; lane 4, A72; lane 5, A73; lane 6, A76; lane 7, A84; lane 8, A94; lane 9, A95; lane 10, A97.

It was verified by PCR and probing of a Southern blot that four isolates of M. intracellulare (7%) contained IS1245 or its related element IS1311. The IS1245 patterns of all four isolates were different (Fig.2). Isolate I4 was isolated from an HIV-negative patient in Cleveland, isolates I33 and I36 were isolated from HIV-positive patients in Arkansas, and isolate I40 was isolated from an HIV-negative patient in Arkansas. The PFGE patterns of these isolates were also unique (data not shown).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

IS1245 patterns of five M. intracellulare isolates. Lane L, ladder (numbers on the left are in kilobase pairs); lane 1, I40; lane 2, I36; lane 3, I33; lane 4, I14; lane 5, I7; lane 6, I4. Lanes 4 and 5 contain M. intracellulare strains that were negative for IS1245 by PCR.

hsp65 sequencing. hsp65 sequencing was used as a secondary method to verify that the 13 M. aviumisolates that did not contain IS1245 were M. avium (Table 2). All of the isolates had an M. avium type; 10 of the isolates had the most commonM. avium types (types 65.1 and 65.2), and the remaining 3 isolates were of type 65.4 (23). The isolates with identical PFGE patterns, isolates A67 and A73, were of hsp65 type 65.34. The four M. intracellulare isolates that contained IS1245 were all typed as M. intracellulare byhsp65 sequencing. Eight of the X isolates had anhsp65 allele, indicating that they were M. avium, three were typed as M. intracellulare, and one had the 65.29 allele, considered “other” in the MAC group (Table3).

View this table:
  • View inline
  • View popup
Table 2.

hsp65 alleles for IS1245-negativeM. avium isolates and IS1245-positive M. intracellulare isolates

View this table:
  • View inline
  • View popup
Table 3.

IS1245, mig, and hsp65allele data for MAC X strains

mig PCR.The only virulence factor identified and well characterized in MAC isolates is the mig gene (14, 16). The mig PCR results indicated that all 92 of theM. avium isolates contained this gene and that none of the 57 M. intracellulare isolates contained mig(Table 1). Therefore, mig appears to be a marker for differentiation of these two species. The isolates designated X varied in their possession of the mig gene. The eight X isolates identified as M. avium and the one isolate identified as “other” by hsp65 sequencing were migpositive, and of these nine isolates, seven contained IS1245(Table 3). The three X isolates which were negative for migwere also negative for IS1245 and were identified asM. intracellulare by their hsp65 sequence.

DISCUSSION

The objective of this study was to use various molecular techniques to define the species of MAC isolated from three patient populations. The most commonly used method for species identification of MAC isolates is based on the ribosomal 16S sequence and is the principle of the Gen-Probe AccuProbes. Generally, the MAC-specific AccuProbe test is used to identify an organism as a member of this group. Most clinical laboratories do not use the species-specific kits to identify the particular species because the kits are expensive and the treatment is the same for each type of MAC infection. Therefore, the exact species causing infection is not known.

Each isolate was identified to the species level with the Gen-Probe AccuProbes. Eighty-five percent of the isolates from HIV-positive patients were identified as M. avium. The isolates from HIV-negative patients were predominately M. intracellulare(86%) and were from individuals with the clinical manifestations of cavitary disease and nodulation or bronchiectasis and a few patients with invasive disease. Thirteen of the HIV-negative patients had no known predisposing factor. The leading predisposing factor for the majority of the other HIV-negative patients was bronchiectasis, with smoking being the next most common factor. It is not clear if bronchiectasis precedes MAC infection or is the result of this infection (12). The few studies performed to look for immune dysfunction in these patients have not identified immune dysfunction in any of the patients at this time (8, 12).

Twelve of the isolates were positive only with the MAC-specific AccuProbe, which defined these strains as being neither M. avium nor M. intracellulare but MAC strain X or nonspecific. When the hsp65 genes of these strains were sequenced, all but one could be identified as either M. avium or M. intracellulare (23). Therefore, many isolates that would not be recognized as M. avium orM. intracellulare with the species-specific Gen-Probe kits can be given a species identification by hsp65 sequencing (Table 3). This is due to the increased variability of thehsp65 gene compared to that of the 16S gene and therefore its greater power of discrimination. hsp65 sequencing was especially useful as a secondary species identification tool for verification that the M. avium isolates without IS1245 were in fact M. avium and that theM. intracellulare isolates with IS1245 were in fact M. intracellulare. There have been two other reports of the identification of M. avium strains without IS1245, but other than tests with Gen-Probe no other method of identification was performed with the strains (1, 19). We do not know the significance of the fact that all of the M. avium isolates that lacked IS1245 were isolated from patients in Great Britain or the Cleveland area. We are continuing our collection of MAC from various geographical sites in order to determine the extent to which M. avium isolates lack the element andM. intracellulare isolates carry the IS1245element. It was interesting to find that many isolates of both M. avium and M. intracellulare contained large plasmids (100 to 300 kb) (data not shown), which, if found to be conjugative, could explain the passage of IS1245 between species (4, 15). Therefore, it appears that the presence of the IS1245 insertion element does not necessarily identify an isolate as M. avium, as has been suggested in other reports (2, 6, 19).

Tests for the detection of the mig gene by PCR were performed because it is the only well-characterized virulence factor identified in MAC (14, 16). The role of this gene has not been elucidated, but the gene has been demonstrated to enhance the growth of organisms residing inside the macrophage (14). It was interesting that all our isolates identified as M. aviumcontain this gene but that the M. intracellulare isolates did not. This finding also held true for the environmental and animal isolates that were examined, but those findings are not included in this report. These results suggest that the detection of themig gene may be a simple and useful way of differentiatingM. avium and M. intracellulare. The presence of this gene in M. avium strains but not M. intracellulare strains suggests that these two species may differ in their virulence mechanisms, which has also been suggested by Maslow et al. (13). The mig gene may be part of a pathogenicity island which is not easily transferred between these two species. Further studies in this regard may reveal the virulence mechanisms used by each species when causing human infections.

In summary, hsp65 sequencing is a useful method for identification of MAC isolates whose species cannot be identified by the AccuProbe Gen-Probe assays. IS1245 is not universally found in all M. avium strains and can be present in M. intracellulare strains. The presence of the mig gene appears to be specific for M. avium strains and may indicate differences in virulence mechanisms between M. avium andM. intracellulare organisms.

ACKNOWLEDGMENTS

This work was funded by an NIH Institutional Development Award Program, Program for the Study of Opportunistic Infections (PAR-96-012).

We thank Chris Hemphill and Suzhannah Mayo for excellent technical assistance. We thank Vivian Jonas and Gen-Probe Inc. for providing some of the species-specific AccuProbe kits. We also express our gratitude to those who sent us the MAC isolates and the patient profile information.

FOOTNOTES

    • Received 29 June 1999.
    • Returned for modification 7 September 1999.
    • Accepted 11 November 1999.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bauer J.,
    2. Anderson A. B.,
    3. Askgaard D.,
    4. Giese S. B.,
    5. Larsen B.
    Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245.J. Clin. Microbiol.371999600605
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Bono M.,
    2. Jemmi T.,
    3. Bernasconi C.,
    4. Burki D.,
    5. Telenti A.,
    6. Bodmer T.
    Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains.Appl. Environ. Microbiol.611995371373
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bull T. J.,
    2. Shanson D. C.
    Evaluation of a commercial chemiluminescent gene probe system “AccuProbe” for the rapid differentiation of mycobacteria, including “MAIC X”, isolated from blood and other sites, from patients with AIDS.J. Hosp. Infect.211992143149
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Crawford J. T.,
    2. Bates J. H.
    Analysis of plasmids in Mycobacterium avium-intracellulare isolates from persons with acquired immunodeficiency syndrome.Am. Rev. Respir. Dis.1341986659661
    OpenUrlPubMed
  5. 5.↵
    1. Ellner J. J.,
    2. Goldberger M. J.,
    3. Parenti D. M.
    Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.J. Infect. Dis.163199113261335
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Guerrero C.,
    2. Bernasconi C.,
    3. Burki D.,
    4. Bodmer T.,
    5. Telenti A.
    A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness.J. Clin. Microbiol.331995304307
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Horsburgh C. R.,
    2. Selik R. M.
    The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).Am. Rev. Respir. Dis.139198947
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Huang J. H.,
    2. Oefner P. J.,
    3. Adi V.,
    4. Ratnam K.,
    5. Ruoss S. J.,
    6. Trako E.,
    7. Kao P. N.
    Analyses of the NRAMP1 and IFN-gR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease.Am. J. Respir. Crit. Care Med.1571998377381
    OpenUrlPubMedWeb of Science
  9. 9.↵
    1. Inderlied C. B.,
    2. Kemper C. A.,
    3. Bermudez L. E. M.
    The Mycobacterium avium complex.Clin. Microbiol. Rev.61993266310
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Iseman M. D.
    M. avium complex: an emerging respiratory pathogen.J. Respir. Dis.161995950962
    OpenUrl
  11. 11.↵
    1. Kapur V.,
    2. Li L.-L.,
    3. Hamrick M. R.,
    4. Plikaytis B. B.,
    5. Shinnick T. M.,
    6. Telenti A.,
    7. Jacobs W. R. Jr.,
    8. Banerjee A.,
    9. Cole S.,
    10. Yuen K. Y.,
    11. Clarridge J. E. III,
    12. Kreisworth B. N.,
    13. Musser J. M.
    Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing.Arch. Pathol. Lab. Med.1191995131138
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Kubo K.,
    2. Yamazaki Y.,
    3. Masubuchi T.,
    4. Takamizawa A.,
    5. Yamamoto H.,
    6. Koizumi T.,
    7. Fujimoto K.,
    8. Matsuzawa Y.,
    9. Honda T.,
    10. Hasegawa M.,
    11. Sone S.
    Pulmonary infection with Mycobacterium avium-intracellulare leads to air trapping distal to the small airways.Am. J. Respir. Crit. Care Med.1581998979984
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Maslow J. N.,
    2. Dawson D.,
    3. Carlin E. A.,
    4. Holland S. M.
    Hemolysin as a virulence factor for systemic infection with isolates of Mycobacterium avium complex.J. Clin. Microbiol.371999445446
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Meyer M.,
    2. von Grünberg P. W. R.,
    3. Knoop T.,
    4. Hartmann P.,
    5. Plum G.
    The macrophage-induced gene mig as a marker for clinical pathogenicity and in vitro virulence of Mycobacterium avium complex strains.Infect. Immun.66199845494552
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Picardeau M.,
    2. Vincent V.
    Characterization of large linear plasmid in mycobacteria.J. Bacteriol.179199727532756
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Plum G.,
    2. Brenden M.,
    3. Clark-Curtiss J. E.,
    4. Pulverer G.
    Cloning, sequencing, and expression of the mig gene of Mycobacterium avium, which codes for a secreted macrophage-induced protein.Infect. Immun.65199745484557
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Prince D. S.,
    2. Peterson D. D.,
    3. Steiner R. M.,
    4. Gottlieb J. E.,
    5. Scott R.,
    6. Israel H. L.,
    7. Figueroa W. G.,
    8. Fish J. E.
    Infection with Mycobacterium avium complex in patients without predisposing conditions.N. Engl. J. Med.321989863868
    OpenUrl
  18. 18.↵
    1. Reich J. M.,
    2. Johnson R. E.
    Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting.Am. Rev. Respir. Dis.143199113811385
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Ritacco V.,
    2. Kremer K.,
    3. van der Laan T.,
    4. Pijnenburg J. E. M.,
    5. de Haas P. E. W.,
    6. van Soolingen D.
    Use of IS901 and IS1245 in RFLF typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates.Int. J. Tuberc. Lung Dis.31998242251
    OpenUrl
  20. 20.↵
    1. Roiz M.,
    2. Palenque E.,
    3. Guerrero C.,
    4. Garcia M.
    Use of restriction fragment length polymorphism as a genetic marker for typing Mycobacterium avium strains.J. Clin. Microbiol.33199513891391
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Shinnick T.
    The 65-kilodalton antigen of Mycobacterium tuberculosis.J. Bacteriol.169198710801088
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Swanson D. S.,
    2. Pan X.,
    3. Kline M. W.,
    4. McKinney R. E. Jr.,
    5. Yogev R.,
    6. Lewis L. L.,
    7. Brady M.,
    8. McSherry G. D.,
    9. Dankner W. M.,
    10. Musser J. M.
    Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection.J. Infect. Dis.1781998776782
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Swanson D. S.,
    2. Kapur V.,
    3. Stockbauer K.,
    4. Pan X.,
    5. Frothingham R.,
    6. Musser J. M.
    Subspecific differentiation of Mycobacterium avium complex strains by automated sequencing of a region of the gene (hsp65) encoding a 65-Kilodalton heat shock protein.Int. J. Syst. Bacteriol.471997414419
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Wallace R. J. Jr.
    Mycobacterium avium complex lung disease in women: now an equal opportunity disease.Chest105199467 (Editorial.)
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Wallace R. J. Jr.,
    2. Zhang Y.,
    3. Brown B. A.,
    4. Dawson D.,
    5. Murphy D. T.,
    6. Wilson R.,
    7. Griffith D. E.
    Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.Am. J. Respir. Crit. Care Med.158199812351244
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Zhang Y.,
    2. Wallace R. J. Jr.,
    3. Mazurek G. H.
    Genetic differences between BCG substrains.Tubercle Lung Dis.7619954350
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques
Marjorie L. Beggs, Rossina Stevanova, Kathleen D. Eisenach
Journal of Clinical Microbiology Feb 2000, 38 (2) 508-512; DOI: 10.1128/JCM.38.2.508-512.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques
Marjorie L. Beggs, Rossina Stevanova, Kathleen D. Eisenach
Journal of Clinical Microbiology Feb 2000, 38 (2) 508-512; DOI: 10.1128/JCM.38.2.508-512.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

AIDS-Related Opportunistic Infections
Mycobacterium avium complex
Mycobacterium avium-intracellulare Infection

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X